Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 8, Number 8—August 2002

Research

Antecedent Treatment with Different Antibiotic Agents as a Risk Factor for Vancomycin-Resistant Enterococcus

Yehuda Carmeli*†Comments to Author , George M. Eliopoulos*†, and Matthew H. Samore*†
Author affiliations: *Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; †Harvard Medical School, Boston, Massachusetts, USA;

Main Article

Table 2

Multivariable explanatory model for having vancomycin-resistant enterococci-positive case

Variable Odds ratio (95% CI) p value
Main admitting disorder 0.44 (0.28 to 0.68) <0.001
Cardiovascular 2.9 (1.5 to 5.7) 0.002
Infectious
Coexisting conditions
Diabetes mellitus 2.1 (1.5 to 3.1) <0.001
Transplant recipient 2.6 (1.6 to 4.5) <0.001
Hepatobiliary disease 2.9 (1.8 to 4.6) <0.001
MRSA (in past yr)
Clostridium difficile (in past yr) 3.5 (1.8 to 6.9)
2.0 (0.97 to 4.3) <0.001
0.06

CI, confidence interval; MRSA, methicillin-resistant Staphylococcus aureus.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO